Immunomodulators for Skin Cancer
September 2004 | Volume 3 | Issue 5 | Original Article | 533 | Copyright © September 2004
Adriana M Villa and MD, Brian Berman MD PhD
Abstract
Therapeutic interventions to augment tumor antigenicity or increase the host’s immune response against cancer cells include recombinant
cytokines, immune modulators, vaccination with tumor antigens, T cell-based immunotherapy, and gene therapy. We describe
the current role of the immunomodulators (up-regulators of the immune response) in the therapy of skin cancer (non melanoma skin
cancer, melanoma, lymphoma, Kaposi sarcoma, and extramammary Paget’s disease). 
